首页> 外文期刊>Current opinion in biotechnology >Vascularized microfluidic organ-chips for drug screening, disease models and tissue engineering
【24h】

Vascularized microfluidic organ-chips for drug screening, disease models and tissue engineering

机译:血管化的微流体器官芯片用于药物筛选,疾病模型和组织工程

获取原文
获取原文并翻译 | 示例
       

摘要

Vascularization of micro-tissues in vitro has enabled formation of tissues larger than those limited by diffusion with appropriate nutrient/gas exchange as well as waste elimination. Furthermore, angiocrine signaling from the vasculature may be essential in mimicking organ-level functions in these micro tissues. In drug screening applications, the presence of an appropriate blood organ barrier in the form of a vasculature and its supporting cells (pericytes, appropriate stromal cells) may be essential to reproducing organ-scale drug delivery pharmacokinetics. Cutting-edge techniques including 3D bioprinting and in vitro angiogenesis and vasculogenesis could be applied to vascularize a range of tissues and organoids. Herein, we describe the latest developments in vascularization and prevascularization of micro-tissues and provide an outlook on potential future strategies.
机译:体外微组织的血管化使得形成大于通过与适当的营养/气体交换的扩散有限的组织的形成以及废物消除。 此外,来自脉管系统的血管素信号传导可能是模拟这些微组织中的器官水平功能的必要条件。 在药物筛选应用中,脉管系统的形式及其支撑细胞(周细胞,适当的基质细胞)存在适当的血器官屏障可能对再现器官级药物递送药代动力学是必不可少的。 包括3D生物监测和体外血管生成和血管生成的尖端技术可用于血管化一系列组织和有机体。 在此,我们描述了微组织血管化和血管内血管形成的最新动态,并提供了潜在的未来策略的展望。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号